Skip to main content
Retour
Watch Compare

Haoxi Health Technology Ltd

Qualité des données : 100%
HAO
Nasdaq Services Business Services
1,07 €
▼ 0,04 € (-3,60%)
Cap. Boursière: 65,98 M
Prix
1,11 €
Cap. Boursière
65,98 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Earnings grew 200,13% over the past year
ROE of 27,06% indicates high profitability
Debt/Equity of 0,08 — conservative balance sheet
Negative free cash flow of -3,41 M
Capital efficient — spends only 0,17% of revenue on capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-32,39%
Earnings (1Y)200,13%
FCF Growth (3Y)N/A

Qualité

Return on Equity
27,06%
Au-dessus de la moyenne du secteur (-15,95%)
ROIC-11,87%
Net Margin11,82%
Op. Margin-6,10%

Sécurité

Debt / Equity
0,08
En dessous de la moyenne du secteur (0,39)
Current Ratio6,02
Interest Coverage-43,52

Valorisation

PE (TTM)
17,02
Au-dessus de la moyenne du secteur (-1,17)
P/B Ratio3,52
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (502 pairs)
Métrique Action Médiane du Secteur
P/E 17,0 -1,2
P/B 3,5 1,4
ROE % 27,1 -16,0
Net Margin % 11,8 -19,4
Rev Growth 5Y % — 4,0
D/E 0,1 0,4

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

All Fundamental Metrics
Growth
Revenue Growth (1Y) -32,39% Revenue Growth (3Y) N/A
Earnings Growth (1Y) 200,13% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 32,80 M Net Income (TTM) 3,88 M
ROE 27,06% ROA 20,90%
Gross Margin 2,83% Operating Margin -6,10%
Net Margin 11,82% Free Cash Flow (TTM) -3,41 M
ROIC -11,87% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,08 Current Ratio 6,02
Interest Coverage -43,52 Asset Turnover 1,77
Working Capital 16,53 M Tangible Book Value 16,73 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 17,02 Forward P/E N/A
P/B Ratio 3,52 P/S Ratio 2,01
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -5,17%
Market Cap 65,98 M Enterprise Value 67,41 M
Per Share
EPS (Diluted TTM) 1,32 Revenue / Share 0,55
FCF / Share -0,06 OCF / Share -0,06
EPS CAGR (1Y) 3200,00% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,17% FCF Conversion -88,05%
SBC-Adj. FCF -3,47 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue 32,80 M 48,52 M
Net Income 3,88 M 1,29 M
EPS (Diluted) 1,32 0,04
Gross Profit 927 750,0 2,75 M
Operating Income -2,00 M 1,72 M
EBITDA — —
R&D Expenses 79 544,0 79 985,0
SG&A Expenses — —
D&A — —
Interest Expense 45 956,0 41 186,0
Income Tax 270 744,0 443 582,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 21,60 M 15,51 M
Total Liabilities 4,22 M 4,23 M
Shareholders' Equity 17,38 M 11,27 M
Total Debt 1,61 M 1,14 M
Cash & Equivalents — 6,66 M
Current Assets 19,60 M 15,38 M
Current Liabilities 3,89 M 3,87 M